XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.2
Unaudited Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2021 $ (3,559) $ (3,559)
Balance (in Shares) at Dec. 31, 2021      
Common stock issued to initial stockholders $ 287 24,713 25,000
Common stock issued to initial stockholders (in Shares) 2,875,000      
Net income (loss) (5,010) (5,010)
Balance at Mar. 31, 2022 $ 287 24,713 (8,569) 16,431
Balance (in Shares) at Mar. 31, 2022 2,875,000      
Balance at Dec. 31, 2021 (3,559) (3,559)
Balance (in Shares) at Dec. 31, 2021      
Net income (loss)       (213,836)
Balance at Jun. 30, 2022 $ 340 (4,280,388) (4,280,048)
Balance (in Shares) at Jun. 30, 2022 3,405,000      
Balance at Mar. 31, 2022 $ 287 24,713 (8,569) 16,431
Balance (in Shares) at Mar. 31, 2022 2,875,000      
Sale of public units in initial public offering $ 1,150 114,998,850 115,000,000
Sale of public units in initial public offering (in Shares) 11,500,000      
Sale of private placement units $ 53 5,299,947 5,300,000
Sale of private placement units (in Shares) 530,000      
Sale of unit purchase option to underwriter 100 100
Underwriter commissions (7,187,500) (7,187,500)
Offering costs (462,536) (462,536)
Warrant Liabilities (587,717) (587,717)
Reclassification of common stock subject to redemption $ (1,150) (96,337,784) (96,338,934)
Reclassification of common stock subject to redemption (in Shares) (11,500,000)      
Allocation of offering costs to common stock subject to redemption 6,901,405 6,901,405
Accretion of common stock to redemption value (22,649,478) (4,062,993) (26,712,471)
Net income (loss) (208,826) (208,826)
Balance at Jun. 30, 2022 $ 340 (4,280,388) (4,280,048)
Balance (in Shares) at Jun. 30, 2022 3,405,000      
Balance at Dec. 31, 2022 $ 340 (4,044,852) (4,044,512)
Balance (in Shares) at Dec. 31, 2022 3,405,000      
Accretion of common stock to redemption value (1,322,195) (1,322,195)
Excise tax liability (631,696) (631,696)
Net income (loss) 1,120,611 1,120,611
Balance at Mar. 31, 2023 $ 340 (4,878,132) (4,877,792)
Balance (in Shares) at Mar. 31, 2023 3,405,000      
Balance at Dec. 31, 2022 $ 340 (4,044,852) (4,044,512)
Balance (in Shares) at Dec. 31, 2022 3,405,000      
Net income (loss)       967,065
Balance at Jun. 30, 2023 $ 340 (6,046,053) (6,045,713)
Balance (in Shares) at Jun. 30, 2023 3,405,000      
Balance at Mar. 31, 2023 $ 340 (4,878,132) (4,877,792)
Balance (in Shares) at Mar. 31, 2023 3,405,000      
Accretion of common stock to redemption value (1,014,375) (1,014,375)
Net income (loss) (153,546) (153,546)
Balance at Jun. 30, 2023 $ 340 $ (6,046,053) $ (6,045,713)
Balance (in Shares) at Jun. 30, 2023 3,405,000